Ambulante Therapie der tiefen Beinvenenthrombose?

Deutsche Medizinische Wochenschrift

Volumn 124, Issue , 1999, Pages 810-815

  Schellong, S M ^a   Schwarz, T ^a   Schroder H E ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; NADROPARIN; TINZAPARIN;

CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; HUMAN; IMMOBILIZATION; INTRAVENOUS DRUG ADMINISTRATION; NOTE; OUTPATIENT CARE; PARTIAL THROMBOPLASTIN TIME;

ADMINISTRATION, ORAL; AMBULATORY CARE; ANTICOAGULANTS; BANDAGES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMOBILIZATION; THROMBOPHLEBITIS;

EID: 0033603291     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1233167     Document Type: Article

References (28)

1. Baron, J. A., C. Cridlcy, E. Weidcrpass, O. Nyrén, M. Linet: Venous thromboembolism and cancer. Lancet 351 (1998), 1077-1080.
2. Bona, R. D., A. D. Hickey, D. M. Wallace: Efficacy and safety of oral anticoagulation in patients with cancer. Thrombos. Hemost. 78 (1997), 137-140.
3. Brandjes, D. P. M., H. R. Böller, H. Heijboer, M. V. Huisman, M. deRijk, H. Jagt, J. Wouterten Cate: Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 349 (1997). 759-762.
4. Caspary, L, V. Hach-Wunderle, M. Ludwig, W. Theiss: Venenthrombose. In: Classen, M., R. Dierkesmann, H. Heimpel, J. R. Kalden. K. M. Koch. J. Meyer. F. A. Spengel. R. Ziegler (Hrsg): Rationelle Diagnostik und Therapie in der Inneren Medizin. (Urban & Schwarzenberg: München 1997), El 1: 1-4.
5. Charbonnier, B. A., J. N. Fiessinger, J. D. Banga, E. Wenzel, P. dʼnAzemar, L. Sagnard: Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. Thrombos. Haemost. 79 (1998), 897-901.
6. Callus, A. S., J. Jackaman, J. Tillett, W. Mills, A. Sycherley: Safely and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet (1986) II, 1293-1296.
7. Hull, R. D., G. E. Raskob, D. Rosenbloom, A. A. Panju, P. BrillEdwards, J. S. Ginsberg, J. Hirsh, G. J. Martin, D. Creen: Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. New Engl. J. Med. 322 (1990), 1260-1264.
8. Koopman, M. M. W., P. Prandoni, F. Piovella, P. Ockelford, D. P. M. Brandjes, J. van der Meer, A. S. Gallus, G. Simonneau, C. H. Chesterman, M. H. Prins, P. M. M. Bossuyt, H. de Haes, A. G. M. van den Belt, L. Sagnard, P. DʼnAzemar: Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-mole-cular-weight heparin administered at home. New Engl. J. Med. 334 (1996), 682-687.
9. Landefeld, C. S., R. J. Beyth: Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Amer. J. Med. 95 (1993), 315-328.
10. Leizorovicz, A., G. Simonneau, H. Décousus, J. P. Boissel: Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. Brit. med. J. 309 (1994), 299-304.
11. Lensing, A. W. A., M. H. Prins, B. L. Davidson, J. Hirsh: Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis. Arch, intern. Med. 155 (1995), 601-607.
12. Levine, M., M. Gent, J. Hirsh, J. Leclerc, D. Anderson, J. Weitz, J. Ginsberg, A. G. Turpie, C. Demers, M. Kovacs, W. Geerts, J. Kas-sis, L. Desjardins, J. Cusson, M. Cruickshank: A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. New Engl. J. Med. 334 (1996), 677-681.
13. Levine, M. N., G. Raskob, S. Landefeld, C. Kearon: Hemorrhagic complications of anticoagulant treatment. Chest 114, Suppl. 5 (1998), 511S-523S.
14. Martin, M.: PHLEKO-/PHLEFI-Studien. Zwei Studien über die Behandlung von Phlebothrombosen mit konservativer und fi-brinolytischer Therapie. Vasa, Suppl. 49 (1997), 5-39.
15. Pacouret, G., D. Alison, J. M. Pottier, P. Bertrand, B. Charbonnier: Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch, intern. Med. 157 (1997), 305-308.
16. Partsch, H.: Diagnose und Therapie der tiefen Venenthrombose. Vasa. Suppl. 46 (1996), 3-53.
17. Partsch, H., B. Kechavarz, H. Kohn, A. Mostbeck: The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin. Int. Angiol. 16 (1997). 189-192.
18. Partsch, H., K. Oburger, A. Mostbeck, B. König, H. Köhn: Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: A prospective study. J. vase. Surg. 16 (1992), 715-722.
19. Prandoni, P.: Antithrombotic strategies in patients with cancer. Thrombos. Hemost. 78 (1997), 141-144.
20. Prins, M. H., R. J. K. Hettiarachchi, A. W. A. Lensing, J. Hirsh: Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see? Thrombos. Hemost. 78 (1997). 121-125.
21. Schellong, S. M., T. Schwarz, J. Kropp, Y. Prescher, B. Beuthien, W. G. Daniel: Bettruhe in der Behandlung der TVT senkt die Inzidenz szintigraphisch neu auftretender Lungenembolien nicht. Vasa, Suppl. 52 (1998), 95.
22. Schwarz, T., S. M. Schellong, J. Kropp, Y. Prescher, H. E. Schröder: Flottierendes Thrombusende und Lungenembolie bei tiefer Beinvenenthrombose. Vasa, Suppl. 52 (1998), 63.
23. Siragusa, S., B. Cosmi, F. Piovella, J. Hirsch, J. S. Ginsberg: Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Amer. J. Med. 155 (1996), 601-607.
24. Stammler, F., C. Diehm: Niedermolekulare Heparine bei venöser Thromboembolie. Dtsch. med. Wschr. 123 (1998). 604-611.
25. Warkentin, T. E., M. N. Levine, J. Hirsh, P. Horsewood, R. S. Roberts, M. Gent, J. G. Keiton: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New Engl. J. Med. 332 (1995), 1330-1335.
26. Weitz, J. I.: Low-molecular-weight heparins. New Engl. J. Med. 337 (1997), 688-698.
27. Wells, P. S., M. J. Kovacs, J. Bormanis, M. A. Forgie, D. Goudie, B. Morrow, J. Kovacs: Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch, intern. Med. 158 (1998). 1809-1812.
28. Wheeler, A. P., R. D. Jaquiss, J. H. Newman: Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Arch, intern. Med. 148 (1988), 1321-1325.